Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company developed a proprietary technology platform that is the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious respiratory and sexually transmitted infections.
$3.9M sweet spot round size
2012
$3.9M
from 1 investors over 1 rounds
Visby Medical raised $3.9M on February 15, 2025
Investors: CARB-X